GBA1 and Parkinson disease: We suggest that GBA mutations and decreased GCase activity increase the risk for PD by inducing or exacerbating these same abnormalities of mitochondrial function, oxidative stress and alpha-synuclein accumulation to cause or accelerate the development of PD.